Board of Directors

Mr Laurence Freedman AM

Non-Executive Chairman based in Sydney, Australia

Mr Freedman was appointed a Director of PET in October, 2010.

Mr Freedman has a long history of involvement and expertise in public companies with international trading and investment activities. He began his career with the Gold Fields Group: initially an analyst, he rose to Director of Group companies. He later joined BT Australia as Manager, Investments.

In 1980 he founded Equitilink Limited, an investment management group which he grew to a global company with operations around the world and over $3 billion under management. He held Chairman and/or Director positions in a number of public and private companies in Australia, the United States, the UK, Canada, New Zealand and Taiwan.

He was a member of the syndicate which bought the Ten Network, of which he became a director, taking it out of receivership and helping to make it the most profitable media network in Australia for some years.

In 2000 he sold the Equitilink Group and in 2004 sold out of the Ten Group.

He currently manages his private investment portfolio of international shares, property and fixed income securities. He is a mentor to a number of resource, biotech and technology companies.

He is Chairman of The Freedman Foundation, a philanthropic foundation funded by the Freedman family, which assists and supports young Australians in many areas of endeavor. The Foundation also finances a broad range of medical and scientific programs and organizations.

In 2001 he was awarded The Order of Australia for service to the community, to medical research, the arts, and to business and investment in Australia.

Mr Freedman is Chairman of Phoslock Environmental Technologies’ Remuneration and Nomination committees and a member of the Audit Committee.

Mr Lachlan McKinnon

Managing Director and CEO

Mr McKinnon was appointed PET Chief Executive Officer in January, 2020, based in Melbourne. Mr McKinnon will be responsible for PET's International businesses and overview of PET's China business.

Mr McKinnon has worked for Nufarm Limited (ASX: NUF) in various management roles in Australia, Europe and North America since 1994. Nufarm is a leading agricultural chemicals business (FY2018/19 Sales $3.8 billion) with manufacturing and marketing operations based in Australia, New Zealand, Asia, Europe and the Americas.

Mr McKinnon has significant overseas sales & marketing experience. He was most recently (2016-19) country manager for Canada and head of marketing for the Americas. Previously, Mr McKinnon has spent four years leading and developing Nufarm's Northern Europe business,

Mr McKinnon holds a Bachelor of Agricultural Science from La Trobe University, Melbourne; Graduate Diploma of Business (Agribusiness) from Monash University Melbourne; Master of Enterprise, School of Enterprise, Melbourne University; and Harvard Business School Short Course - Agribusiness

Mrs Brenda Shanahan

Non-Executive Director based in Melbourne, Australia

Mrs. Brenda Shanahan is a Graduate of Melbourne University in Economics and Commerce and a Fellow of the Institute of Directors. She has a research background in finance in Australian and overseas economies and share markets. Previously, she held executive positions included Managing Director of W M Mercer Investment Consulting for Australia and Asia and a member of their international board.

Mrs. Shanahan is a former Director of Equitilink Limited and former non-executive director of Australian Stock Exchange Listed Challenger Financial Services as an independent non-executive director of Challenger Limited, where she is a member of the group Risk Committee, Group Audit Committee, Remuneration Committee and Nomination Committee.

She is also a director of Bell Financial Group Ltd, Clinuvel Pharmaceuticals Ltd, DMP Asset Management Ltd, St Vincent's Medical Research Institute in Melbourne Foundation and the Chair of the Aitkenhead Centre for Medical Discovery. Recently she was bestowed with an honorary Doctorate from Swinburne University of Technology.

Mr Matthew Parker

Chief Financial Officer and Company Secretary

Mr Parker was appointed as PET’s Group Chief Financial Officer in May 2020. Mr Parker is an experienced finance professional having previously held the position of Group CFO of Private Equity owned portfolio businesses and ASX listed entities. Mr Parker has also held key finance roles at the Ford Motor Company and Cadbury Schweppes. Prior to joining Phoslock, Mr Parker was the CFO of GALE Pacific Limited (ASX:GAP).

Mr Parker is a Certified Practising Accountant and holds a Bachelors degree in Business (Accounting) and Arts (Japanese). He is a registered member of CPA Australia and an affiliate of the Securities Institute of Australia.

 Barry George Sechos

Non-Executive Director

Barry Sechos has over 30 years' experience as a director, business executive and corporate lawyer. Barry is a Director of the Sherman Group Pty Limited, a privately owned investment company located in Sydney, Australia. Barry is also a Director and Principal of Paddington St Finance Pty Limited, a specialist structured finance company providing R&D Tax Incentive Finance and Mid-Market Corporate Loans to emerging corporations domiciled in Australia and Fulcrum Media Finance Pty Limited, a finance company providing Producer Offset Finance to Australian and New Zealand film production companies.

Barry is also a director of See-Saw Films, an Australian and UK based film production and finance group and winner of the 2011 Academy Award for Best Picture for The King's Speech and producer of the multi Academy Award nominated film Lion; Transmission Films, an Australian film distribution company; Regeneus Limited, an Australian based regenerative medicine company listed on the Australian Securities Exchange and which focuses on using the regenerative capacities of stem cells to develop innovative cell therapies for humans and animals; and Concentrated Leaders Fund Limited, an investment company listed on the Australian Securities Exchange and which invests primarily in Australian companies within the S&P/ASX200 Accumulation Index.

Barry commenced his professional career as a commercial lawyer at the law firm Allen Allen & Hemsley, specialising in banking & finance law at Allens' Sydney office and worked in Allens' Singapore and London offices.